- : Ms Word Format
- : Pages
- : ₦3000
- : 1-5 Chapters
- Click to DOWNLOAD Materials
THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY CORPORATE GOVERNANCE AND BOARD OVERSIGHT.
Abstract:
The integration of financial technology (fintech) has revolutionized various industries, including the pharmaceutical sector. As pharmaceutical companies increasingly adopt and rely on fintech solutions, it is crucial to examine the impact of this technological disruption on corporate governance and board oversight within these organizations. This abstract provides a brief overview of the key findings and implications of such impact.
The study investigates the ways in which fintech influences corporate governance mechanisms and board oversight practices in pharmaceutical companies. It explores the challenges, opportunities, and changes that arise as a result of fintech adoption. The research utilizes a mixed-method approach, combining qualitative interviews with relevant stakeholders and quantitative analysis of financial and governance data.
The findings highlight several key impacts of fintech on corporate governance and board oversight in pharmaceutical companies. Firstly, fintech enables more efficient and transparent financial reporting and auditing processes, reducing the risk of financial fraud and improving accountability. Secondly, it enhances data analytics capabilities, enabling boards to make more informed decisions and monitor organizational performance in real-time. Additionally, fintech facilitates greater engagement and collaboration between board members, allowing for faster and more effective decision-making.
However, the study also identifies potential challenges associated with fintech implementation in the pharmaceutical industry. These challenges include data privacy and security concerns, regulatory compliance issues, and the need for enhanced digital literacy among board members. Moreover, the study highlights the importance of effective risk management strategies to address potential cybersecurity threats and ensure the integrity and reliability of fintech systems.
The implications of this research suggest that pharmaceutical companies should embrace fintech innovations strategically, taking into account the unique governance needs of the industry. Boards should prioritize the development of digital literacy and expertise among its members and establish robust risk management frameworks. Regulatory bodies should also work collaboratively with the industry to develop appropriate guidelines and frameworks to govern fintech adoption.
In conclusion, the integration of fintech in the pharmaceutical industry has a profound impact on corporate governance and board oversight. While it brings numerous benefits, it also poses challenges that need to be proactively addressed. By adopting a strategic and proactive approach, pharmaceutical companies can leverage fintech to enhance governance practices and ensure sustained organizational success in an increasingly digital era.
Keywords: Fintech, pharmaceutical industry, corporate governance, board oversight, financial technology, digital transformation, data analytics, risk management.
